CTT Pharmaceutical Holdings (CTTH) Stock Statistics & Valuation Metrics
Total Valuation
CTT Pharmaceutical Holdings has a market cap or net worth of $3.52M. The enterprise value is $1.71T.
- Market Cap
- $3.52M
- Enterprise Value
- $1.71T
Share Statistics
CTT Pharmaceutical Holdings has 59,722,233 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 59,722,233
- Owned by Insiders
- 15.80%
- Owned by Institutions
- ―
Financial Efficiency
CTT Pharmaceutical Holdings’s return on equity (ROE) is -2.83 and return on invested capital (ROIC) is -171.42%.
- Return on Equity (ROE)
- -2.83
- Return on Assets (ROA)
- -1.81
- Return on Invested Capital (ROIC)
- -171.42%
- Return on Capital Employed (ROCE)
- -2.30
- Revenue Per Employee
- 0
- Profits Per Employee
- -155.91K
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of CTT Pharmaceutical Holdings is -45.38. CTT Pharmaceutical Holdings’s PEG ratio is 1.51.
- PE Ratio
- -45.38
- PS Ratio
- 0.00
- PB Ratio
- 135.30
- Price to FCF
- -65.48
- Price to Operating Cash Flow
- -65.48
- PEG Ratio
- 1.51
Income Statement
In the last 12 months, CTT Pharmaceutical Holdings had revenue of 0 and earned -155.91K in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- -6,432
- Operating Income
- -126.77K
- Pretax Income
- -155.91K
- Net Income
- -155.91K
- EBITDA
- -120.34K
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -53.81K and capital expenditures 5, giving a free cash flow of -53.81K billion.
- Operating Cash Flow
- -53.81K
- Free Cash Flow
- -53.81K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
CTT Pharmaceutical Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.53%
- Earnings Yield
- -4.70%
Stock Price Statistics
- Beta
- 0.16
- 52-Week Price Change
- -14.49%
- 50-Day Moving Average
- 0.05
- 200-Day Moving Average
- 0.07
- Relative Strength Index (RSI)
- 53.62
- Average Volume (3m)
- 36.43K
Financial Position
CTT Pharmaceutical Holdings as a current ratio of 0.50, with Debt / Equity ratio of 34.11%
- Current Ratio
- 0.50
- Quick Ratio
- 0.50
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.03
- Interest Coverage Ratio
- -63.26
Taxes
In the past 12 months, CTT Pharmaceutical Holdings has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
CTT Pharmaceutical Holdings EV to EBITDA ratio is -28.88, with an EV/FCF ratio of -65.85.
- EV to Sales
- 0.00
- EV to EBITDA
- -28.88
- EV to Free Cash Flow
- -65.85
- EV to Operating Cash Flow
- -65.84
Balance Sheet
CTT Pharmaceutical Holdings has $31.00 in cash and marketable securities with $19.44K in debt, giving a net cash position of -$19.41K billion.
- Cash & Marketable Securities
- $31.00
- Total Debt
- $19.44K
- Net Cash
- -$19.41K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for CTT Pharmaceutical Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 12.50%
